FUNDING INFORMATION
ALF, Cancer
CANCER
This work is supported by the Swedish Cancer Society 180685, the Swedish Research Council 2017–01744, the Swedish Research Council for Health, Workinglife and Welfare 2017–00812, The Cancer Research Funds of Radiumhemmet 171103 and Region Stockholm (ALF) LS 2018–1157. Pernilla Lagergren is supported by the NIHR Imperial Biomedical Research Centre (BRC) for her position at Imperial College London, London, United Kingdom.